发明授权
US07052691B2 Methods of treating diabetes by blocking VEGF-mediated activity
有权
通过阻断VEGF介导的活性治疗糖尿病的方法
- 专利标题： Methods of treating diabetes by blocking VEGF-mediated activity
- 专利标题（中）： 通过阻断VEGF介导的活性治疗糖尿病的方法
-
申请号： US10811170申请日： 2004-03-26
-
公开(公告)号： US07052691B2公开(公告)日： 2006-05-30
- 发明人: Mark W. Sleeman , Stanley J. Wiegand
- 申请人： Mark W. Sleeman , Stanley J. Wiegand
- 申请人地址： US NY Tarrytown
- 专利权人： Regeneron Pharmaceuticals, Inc.
- 当前专利权人： Regeneron Pharmaceuticals, Inc.
- 当前专利权人地址： US NY Tarrytown
- 代理商 Valeta Gregg, Esq.
- 主分类号： A61K38/18
- IPC分类号： A61K38/18 ; C07K14/71 ; C12N15/62
摘要：
Methods of treating diabetes in mammals, particularly humans, by blocking or inhibiting VEGF-mediated activity. A preferred inhibitor of VEGF-mediated activity is a VEGF antagonist such as a VEGF trap capable of binding and blocking VEGF.
公开/授权文献
信息查询
IPC分类:
